TRAPHAGEN INVESTMENT ADVISORS LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0002023380
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q1 2026 · 207 positions · Total reported value $1.23B · Top-10 concentration 64.3% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 36.2% · 16 new · 61 cut · 8 exited
Active Share (vs S&P 500): 88.0% · vs QQQ: 92.5% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): +0.0% · vs SPY -2.1% · Prev Value $1.40B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +1.1% · vs SPY -1.1% · Latest Value $1.46B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q1 2026 13F filing, TRAPHAGEN INVESTMENT ADVISORS LLC disclosed 207 equity positions with a combined reported value of $1.23B. The filing implies a focused portfolio: its ten largest positions account for 64.3% of reported value. HoldingsHub classifies the profile as Mid / Focused / High Turnover.
The largest disclosed positions as of Q1 2026 were IVV ($311.17M), AVUS ($117.16M), VFLO ($86.14M). By sector, the heaviest allocations are Technology 5.7%, Financials 5.1%. Versus the prior quarter, allocation shifted toward Other (+0.7pp), Energy (+0.6pp) and away from Technology (-0.5pp).
Versus the prior quarter, TRAPHAGEN INVESTMENT ADVISORS LLC opened 16 new positions, trimmed 61 and fully exited 8, a turnover rate of 36.2% of positions. The portfolio's overlap with the prior quarter was 87% of names.
The largest new positions opened in Q1 2026 were FENI ($25.93M), TXXI ($1.30M), UBS ($380.72K).
Of the 8 positions fully exited versus the prior quarter, the largest were ULTA ($350.99K), UNH ($342.91K), SPGI ($265.92K).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q1 2026)
Fully Exited (vs previous quarter)
- ULTA ULTA BEAUTY INC · prev qtr: $350.99K
- UNH UNITEDHEALTH GROUP INC · prev qtr: $342.91K
- SPGI S&P GLOBAL INC · prev qtr: $265.92K
- CTRE CARETRUST REIT INC · prev qtr: $241.76K
- GDLC GRAYSCALE COINDESK CRYPTO 5 ETF · prev qtr: $225.04K
- EFA ISHARES TR · prev qtr: $204.51K
- BKN BLACKROCK INVT QUALITY MUN T · prev qtr: $124.49K
- DYAI DYADIC INTL INC DEL · prev qtr: $12.22K
Insider Transactions (Form 4)
Latest TRAPHAGEN INVESTMENT ADVISORS LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Traphagen Investment Advisors is an SEC-registered 13F filer based in Oradell, NJ, United States. As of Q3 2026 it reported 227 US equity positions with a combined value of $1.46B. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Firm Snapshot
- Headquarters: ORADELL, NJ, United States
- SEC registration: 801-56130 (status: Approved), registered 1999-01-07
- Regulatory AUM (Form ADV): $2.17B as of 2026-03-02
- Client mix (by RAUM): individual investors 91%, pension and profit-sharing plans 9%
Portfolio Structure
- 227 positions · $1.46B reported value (Q3 2026)
- Top 10 holdings = 66.7% of reported value
- Largest position: IVV (ISHARES TR) at 25.5%
- Average position size: $6.43M
Sector Tilt
- Information Technology 6.8%
- Financials 4.9%
- Consumer Discretionary 1.3%
- (classified holdings cover 16% of value)
Quarterly Activity
- Q3 2026: 16 new, 93 added, 61 reduced, 8 exited
- 57 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
476.37K | $311.17M | 25.21% | Add | |
| 2 |
|
1.05M | $117.16M | 9.49% | Reduce | |
| 3 |
|
2.18M | $86.14M | 6.98% | Reduce | |
| 4 |
|
1.01M | $52.13M | 4.22% | Add | |
| 5 |
|
280.15K | $45.83M | 3.71% | Reduce | |
| 6 |
|
859.92K | $43.31M | 3.51% | Add | |
| 7 |
|
865.83K | $36.68M | 2.97% | Add | |
| 8 |
|
141.41K | $35.89M | 2.91% | Add | |
| 9 |
|
1.33M | $34.92M | 2.83% | Add | |
| 10 |
|
889.01K | $29.99M | 2.43% | Reduce | |
| 11 |
|
697.00K | $25.93M | 2.10% | New | |
| 12 |
|
256.76K | $25.85M | 2.09% | Reduce | |
| 13 |
|
433.83K | $25.83M | 2.09% | Reduce | |
| 14 |
|
397.29K | $23.47M | 1.90% | Add | |
| 15 |
|
1.01M | $21.61M | 1.75% | Add | |
| 16 |
|
1.17M | $19.45M | 1.58% | Add | |
| 17 |
|
24.06K | $14.38M | 1.17% | Hold | |
| 18 |
|
48.55K | $14.34M | 1.16% | Hold | |
| 19 |
|
44.59K | $14.30M | 1.16% | Add | |
| 20 |
|
153.12K | $12.64M | 1.02% | Reduce | |
| 21 |
|
303.17K | $11.16M | 0.90% | Add | |
| 22 |
|
318.82K | $10.53M | 0.85% | Add | |
| 23 |
|
14 | $10.05M | 0.81% | Hold | |
| 24 |
|
56.18K | $8.84M | 0.72% | Hold | |
| 25 |
|
10.14K | $8.58M | 0.69% | Hold | |
| 26 |
|
229.77K | $7.05M | 0.57% | Add | |
| 27 |
|
39.75K | $6.93M | 0.56% | Add | |
| 28 |
|
15.46K | $5.72M | 0.46% | Hold | |
| 29 |
|
48.15K | $5.11M | 0.41% | Reduce | |
| 30 |
|
218.30K | $5.02M | 0.41% | Add | |
| 31 |
|
60.03K | $4.86M | 0.39% | Add | |
| 32 |
|
84.56K | $4.46M | 0.36% | Reduce | |
| 33 |
|
8.58K | $4.11M | 0.33% | Hold | |
| 34 |
|
13.86K | $3.98M | 0.32% | Reduce | |
| 35 |
|
19.08K | $3.97M | 0.32% | Hold | |
| 36 |
|
33.42K | $3.96M | 0.32% | Hold | |
| 37 |
|
13.45K | $3.96M | 0.32% | Add | |
| 38 |
|
11.85K | $3.90M | 0.32% | Hold | |
| 39 |
|
53.49K | $3.35M | 0.27% | Reduce | |
| 40 |
|
86.58K | $3.33M | 0.27% | Add | |
| 41 |
|
11.04K | $3.18M | 0.26% | Reduce | |
| 42 |
|
14.37K | $2.97M | 0.24% | Add | |
| 43 |
|
111.89K | $2.87M | 0.23% | Hold | |
| 44 |
|
16.59K | $2.82M | 0.23% | Add | |
| 45 |
|
4.14K | $2.69M | 0.22% | Add | |
| 46 |
|
50.84K | $2.55M | 0.21% | Add | |
| 47 |
|
9.71K | $2.37M | 0.19% | Reduce | |
| 48 |
|
54.60K | $2.29M | 0.19% | Hold | |
| 49 |
|
3.19K | $2.26M | 0.18% | Reduce | |
| 50 |
|
85.56K | $2.15M | 0.17% | Hold | |
FAQ
What did TRAPHAGEN INVESTMENT ADVISORS LLC buy in 2026-Q1?
In its 2026-Q1 13F filing, TRAPHAGEN INVESTMENT ADVISORS LLC reported 207 equity positions worth $1.23B in aggregate; its largest disclosed positions were IVV ($311.17M), AVUS ($117.16M), VFLO ($86.14M).
How large is TRAPHAGEN INVESTMENT ADVISORS LLC's portfolio?
TRAPHAGEN INVESTMENT ADVISORS LLC reported $1.23B of long equity holdings across 207 positions as of 2026-Q1. Top-10 holdings account for 64.3% of reported value.
What is TRAPHAGEN INVESTMENT ADVISORS LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.